Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
venBio is a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs. They are mindful of potential acquisition partners from the outset, and they ensure that their companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is venBio's primary investment focus?
- venBio is a life sciences investment firm that focuses on novel therapeutics for unmet medical needs, partnering with industry leaders to build game-changing medicines and technologies.
- When was venBio founded?
- venBio was founded in 2011.
- Where is venBio headquartered?
- venBio is headquartered in San Francisco, CA, USA.
- What is a notable recent fundraising activity for venBio?
- According to startupim data, venBio raised $528 million for life sciences investment as of August 1, 2024.
- What is venBio's total managed assets?
- venBio manages $2 billion in assets.
- Can you name a key portfolio company for venBio and its investment details?
- venBio led a $111 million investment in ImmPACT Bio in January 2022. ImmPACT Bio was founded in 2017 and raised a total of $137 million.
- Has venBio had any exits recently?
- Yes, ImmPACT Bio, a venBio portfolio company, was acquired by Lyell Immunopharma in October 2024 for an undisclosed amount.
- What sectors does venBio concentrate its investments in?
- venBio concentrates its investments in the Health Tech & Life Sciences sector, with tags including life-sciences, biotechnology, healthcare, and therapeutics.